Select Committee · Science and Technology Committee (Commons)
The role of technology, research and innovation in the COVID-19 recovery
Status: Closed
Opened: 24 Jul 2020
Closed: 19 Feb 2024
Inquiry scope
In addition to its health impacts, the COVID-19 pandemic has disrupted economic activity, with the OECD estimating that the initial impact on the UK has been a reduction in GDP of more than 25% since the end of March. Research and innovation activity has been affected, with the Campaign for Science and Engineering reporting financial and logistical difficulties for academic institutes, medical research charities and businesses. This is particularly important given the ability of research and innovation to drive economic growth as the UK seeks to recover from the pandemic, with UKRI having previously estimated that every £1 spent on research and development delivers £7 in economic and social benefit. The House of Commons Science and Technology Committee will inquire formally into the role of technology, research and innovation in the UK’s economic recovery from COVID-19, as well as the support that the sector itself requires to recover from the pandemic. Read the call for evidence for more information about this inquiry .Oral evidence sessions
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Date | Session and witnesses | Source |
|---|---|---|
| 6 Jul 2022 |
Panel 3
Eion McFadden · Department for Economy (Northern Ireland),
Gordon Lyons MLA · Northern Ireland Assembly,
Jack Morrow · RETìníZE,
Keith Forster · Department for Economy (Northern Ireland),
Matthew Malcolm · Arts Council Northern Ireland,
Professor Nola Hewitt-Dundas · Queens University Belfast,
Professor Paul Moore · Future Screens,
Tim Brundle · Ulster University
|
View ↗ |
| 25 Nov 2021 |
Oral evidence session
Andy Street CBE · West Midlands Combined Authority,
Dr Clive Hickman · The Manufacturing Technology Centre,
Professor Daniel Smith · Cobra Biologics,
Professor Martin Freer · Energy Research Accelerator (ERA),
Professor Simon Collinson · City-REDI, University of Birmingham,
Stephen Malone · Malone Group,
Tony Kinsella · Lucideon
|
View ↗ |
| 23 Sep 2021 |
Oral evidence session
Chris Oglesby · Bruntwood SciTech,
Dr Charles Knight · University of Salford,
Dr Marianne Sensier · University of Manchester,
James Baker · Open Rights Group,
Professor Luke Gheorgiou · University of Manchester,
Professor Richard Jones · The University of Manchester,
Richard Jeffery · GC Business,
Simon Cohen · Innovate Pharmaceuticals
|
View ↗ |
| 21 Apr 2021 |
Oral evidence session
Hetan Shah · British Academy,
Hilary Reynolds CBE · Association of Medical Research Charities,
Naomi Weir · CBI,
Sir Adrian Smith · Royal Society,
Verity Davidge · Make UK
|
View ↗ |
Who gave evidence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Witness | Organisation | Sessions |
|---|---|---|
| Andy Street CBE · Mayor | West Midlands Combined Authority | 1 |
| Chris Oglesby · Exec Chair | Bruntwood SciTech | 1 |
| Dr Charles Knight · Associate Dean | University of Salford | 1 |
| Dr Clive Hickman · Chief Executive | The Manufacturing Technology Centre | 1 |
| Dr Marianne Sensier · Research Fellow | University of Manchester | 1 |
| Eion McFadden · Principal of Economic Strategy Group | Department for Economy (Northern Ireland) | 1 |
| Gordon Lyons MLA · Junior Minister, the Executive Office | Northern Ireland Assembly | 1 |
| Hetan Shah · chief executive | British Academy | 1 |
| Hilary Reynolds CBE · Chief Executive | Association of Medical Research Charities | 1 |
| Jack Morrow · Chief Technology Officer | RETìníZE | 1 |
| James Baker · Program Manager | Open Rights Group | 1 |
| Keith Forster · Director of Economic Strategy Group | Department for Economy (Northern Ireland) | 1 |
| Matthew Malcolm · Creative Industries Development Officer | Arts Council Northern Ireland | 1 |
| Naomi Weir · Head of Innovation | CBI | 1 |
| Professor Daniel Smith · Executive Director, Global Cell and Gene Therapy Portfolio | Cobra Biologics | 1 |
| Professor Luke Gheorgiou · Deputy President and Deputy Vice-Chancellor | University of Manchester | 1 |
| Professor Martin Freer · Director | Energy Research Accelerator (ERA) | 1 |
| Professor Nola Hewitt-Dundas · Pro-Vice-Chancellor for Faculty of Arts, Humanities and Social Science | Queens University Belfast | 1 |
| Professor Paul Moore · Director | Future Screens | 1 |
| Professor Richard Jones · Chair in Materials Physics and Innovation Policy | The University of Manchester | 1 |
| Professor Simon Collinson · Director | City-REDI, University of Birmingham | 1 |
| Richard Jeffery · National Director | GC Business | 1 |
| Simon Cohen · CEO | Innovate Pharmaceuticals | 1 |
| Sir Adrian Smith · President | Royal Society | 1 |
| Stephen Malone · Group CEO | Malone Group | 1 |
| Tim Brundle · Director of Research & Impact | Ulster University | 1 |
| Tony Kinsella · Chief Executive | Lucideon | 1 |
| Verity Davidge · Director of Policy and Public Affairs | Make UK | 1 |
Correspondence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.